|
Andreou et al. [15] |
Overall survival |
|
Variable (bivariate analysis) | value |
Sex | |
Age (higher) | |
Extremity versus axial + pelvis | |
Tumor volume (0–100 cc vs. >100 cc) | |
Grade tumor | |
Local recurrences | |
Distant metastasis | |
Surgical margins | |
Type of surgery | |
Low grade: ablative versus limb-sparing | |
High grade: ablative versus limb-sparing | |
Pathologic fracture | |
ACJCC | |
Multi disc. versus support. care | |
Variable (multivariate analysis) | |
High grade: RR = 5 | |
Axial + pelvis: RR = 2 | |
|
Staals et al. [25] |
Disease-free survival |
|
Variable (bivariate analysis) | value |
Gender | NS |
Age | NS |
Duration of symptoms | NS |
Lesion size | NS |
Anatomic location | NS |
Stage 3 versus Stage 2a | |
Stage 3 versus Stage 2b | |
Stage 2a versus Stage 2b | |
Histologic subtype, MFH versus OS | |
Histologic subtype, MFH versus fibr. sarc. | |
Histologic subtype, OS versus fibr. sarc. | |
Grade 3DD versus grade 4DD | |
Percentage of DD component | |
Percentage of DD component, >50% versus <50% | |
Limb-sparing versus resection | |
Surgery versus surgery + chemotherapy | |
Variable (multivariate analysis, overall survival) | |
Percentage of DD component | |
|
Angelini et al. [16] |
Overall survival |
|
Variable (bivariate analysis) | value |
G1: wide versus intralesional | |
G1: extremity versus trunk | |
G2: wide versus intralesional | |
G2: extremity versus trunk | |
G2: resect. versus amputation | |
G3: extremity versus trunk | |
G3: resect. versus amputation | |
Variable (multivariate analysis) | |
G3: resect. versus amputation | |
G3: extr. versus trunk | |
|
van Maldegem et al. [26] |
Overall survival from the day of unresectability |
|
Variable (bivariate analysis) | value |
Only local unresectable disease versus local unresectable disease + metastasis | |
Age (<40 years) | |
Grade II tumors | |
Sex | NS |
Site | NS |
Resectable versus nonresectable disease at primary diagnosis | NS |
Systemic treatment | |
|